Medical Imaging in North Carolina

Data Spectrum Corporation is the world's leading supplier of high-quality SPECT phantoms and molecular imaging quality control devices. Founded in 1981 and headquartered in Durham, North Carolina, the company manufactures phantoms and inserts for acceptance testing, quality control, and research validation of Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and combined medical imaging systems. Data Spectrum phantoms are the accreditation standard used by the American College of Radiology (ACR) for all nuclear and molecular imaging system evaluations. The company's product portfolio includes the Jaszczak Phantom and related accessories designed to enable medical imaging professionals to evaluate image resolution, validate system performance, and ensure imaging accuracy. All products are designed and manufactured in the United States to meet strict quality control guidelines. Data Spectrum serves the medical imaging profession globally, providing phantoms and quality assurance tools essential for clinical imaging departments, research institutions, and imaging equipment manufacturers seeking regulatory compliance and performance validation.

Convergent Imaging Solutions develops advanced image fusion and nuclear medicine software solutions for healthcare facilities. The company's flagship product, UniSyn MI™ software, provides comprehensive image fusion capabilities across multiple modalities including PET/CT, SPECT/CT, and PET/MR imaging. UniSyn MI supports local, remote, and hybrid deployment models with seamless PACS integration and configurable viewing and processing options. The software serves four primary clinical specialties: oncology (diagnosis, staging, recurrence detection, and treatment response evaluation), general nuclear medicine (planar, gated, and dynamic imaging analysis), cardiology (leveraging partnerships with Cedars-Sinai for cardiac processing), and neurology (neuroradiology imaging). The company also provides radiopharmaceutical dosimetry solutions for theranostic applications including metastatic neuroendocrine tumors, differentiated thyroid cancer, metastatic prostate cancer, and primary/metastatic liver disease. Convergent Imaging Solutions emphasizes workflow optimization, customizable solutions tailored to individual facility needs, and dedicated expert support. The company has received FDA 510(k) clearance for its MRT Dosimetry module. Based in Ottawa, Ontario, Canada, the company supports radiology and nuclear medicine professionals globally, serving as a workflow-optimized software provider for precision diagnostic imaging.

TeraRecon, Inc. is a healthcare software company specializing in AI-powered advanced medical imaging visualization and enterprise image management solutions. The company delivers SaaS-based platforms—TeraRecon AV (registered as Intuition globally) and TeraRecon DETECT—that combine advanced 3D visualization with AI-driven automation to enhance diagnostic precision and clinical workflow efficiency. Products support radiology, cardiology, neurology, vascular surgery, and oncology applications with features including medical image viewing, AI biomarker detection, real-time decision support, and enterprise imaging consolidation. Founded in 1997 and based in Durham, North Carolina, TeraRecon serves approximately 1,900 clinical sites globally with ~195-244 employees and ~$41M annual revenue. The platform emphasizes interoperability, enabling integration with existing hospital imaging systems while automating routine interpretation tasks and reducing clinician time-to-diagnosis.